Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity
The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
The sedative drug thalidomide ([+]-alpha-phthalimidoglutarimide), once abandoned for causing birth defects in humans, has found new therapeutic license in leprosy and other diseases, with renewed teratological consequences. Although the mechanism of teratogenesis and determinants of risk remain unclear, related teratogenic xenobiotics are bioactivated by embryonic prostaglandin H synthase (PHS) to a free-radical intermediates that produce reactive oxygen species (ROS), which cause oxidative damage to DNA and other cellular macromolecules. Similarly, thalidomide is bioactivated by horseradish peroxidase, and oxidizes DNA and glutathione, indicating free radical-mediated oxidative stress. Furthermore, thalidomide teratogenicity in rabbits is reduced by the PHS inhibitor acetylsalicylic acid, indicating PHS-catalyzed bioactivation. Here, we show in rabbits that thalidomide initiates embryonic DNA oxidation and teratogenicity, both of which are abolished by pre-treatment with the free radical spin trapping agent alpha-phenyl-N-t-butylnitrone (PBN). In contrast, in mice, a species resistant to thalidomide teratogenicity, thalidomide does not enhance DNA oxidation, even at a dose 300% higher than that used in rabbits, providing insight into an embryonic determinant of species-dependent susceptibility. In addition to their therapeutic implications, these results constitute direct evidence that the teratogenicity of thalidomide may involve free radical-mediated oxidative damage to em…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They may cause direct cytotoxicity by inducing free radical mediated DNA damage.80”
From Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management (2024) · cites this paper as [80]
Citations
Cites
8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions.
Cheng, K. C., Cahill, D. S., Kasai, H., Nishimura, S., & Loeb, L. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48474-8 · Cited by 1,844
A short history of thalidomide embryopathy
Lenz, W. (1988) · Teratology · doi:10.1002/tera.1420380303 · Cited by 784
Biochemical Toxicology of Chemical Teratogenesis
Wells, P. G., & Winn, L. M. (1996) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239609110574 · Cited by 160
Self-citationThalidomide teratogenesis: evidence for a toxic arene oxide metabolite.
Gordon, G., Spielberg, S. P., Blake, D. A., & Balasubramanian, V. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2545 · Cited by 153
Schumacher, H., Smith, R. L., & Williams, R. T. (1965) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1965.tb02054.x · Cited by 144
Winn, L. M., & Wells, P. G. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00340-1 · Cited by 129
Self-citationProposed mechanisms of action in thalidomide embryopathy
Stephens, T. D. (1988) · Teratology · doi:10.1002/tera.1420380307 · Cited by 111
Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity1
Winn, L. M., & Wells, P. G. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00193-2 · Cited by 102
Self-citationFree Radical Intermediates of Phenytoin and Related Teratogens
Parman, T., Chen, G., & Wells, P. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25079 · Cited by 93
Self-citationCharacterization of a novel cytochrome P450 from the transformable cell line, C3H/10T1/2
Pottenger, L. H., & Jefcoate, C. R. E. (1990) · Carcinogenesis · doi:10.1093/carcin/11.2.321 · Cited by 88
Research works printed but not linked: 1
- Arlen, R.R. & Wells, P.G. Extracellular thiol-disulfide status reflecting chemical toxicity mediated via oxidative stress: Validation with paraquat and t-butylhydroperoxide and implications for phenytoin and thalidomide teratogenicity. FASEB J. 4, A608 (1990).
Cited by
Items 201–300 of 535
Chowdhury, G., Shibata, N., Yamazaki, H., & Guengerich, F. P. (2013) · Chemical Research in Toxicology · doi:10.1021/tx4004215 · Cited by 38
Epperly, M. W., Tyurina, Y. Y., Nie, S., Niu, Y. Y., Zhang, X., Kagan, V. E., & Greenberger, J. S. (2005) · PubMed · Cited by 38
The History and Implications of Testing Thalidomide on Animals
Greek, R., Shanks, N., & Rice, M. J. (2011) · The Journal of Philosophy Science & Law · doi:10.5840/jpsl20111133 · Cited by 38
Whole embryo culture: a “New” technique that enabled decades of mechanistic discoveries
Ellis‐Hutchings, R. G., & Carney, E. W. (2010) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20263 · Cited by 38
Thalidomide treatment in multiple myeloma
Strasser, K., & Ludwig, H. (2002) · Blood Reviews · doi:10.1016/s0268-960x(02)00031-0 · Cited by 37
Safety Profile of Thalidomide after 53 Weeks of Oral Administration in Beagle Dogs
Teo, S. K., Evans, M. G., Brockman, M. J., Ehrhart, J., Morgan, J. M., Stirling, D. I., & Thomas, S. D. (2001) · Toxicological Sciences · doi:10.1093/toxsci/59.1.160 · Cited by 36
Hart, L., Rauch, A. M., Carr, A. M., Vermeesch, J. R., & O’Driscoll, M. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.014464 · Cited by 35
Bian, C., Qin, W.-J., Zhang, C., Zou, G.-L., Zhu, Y., Chen, J., Zhao, R., Wang, Y., & Zhe, H. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.423 · Cited by 35
Selective leukemic-cell killing by a novel functional class of thalidomide analogs
Ge, Y., Montano, I., Rustici, G., Freebern, W. J., Haggerty, C. M., Cui, W., Ponciano‐Jackson, D., Chandramouli, G. V. R., Gardner, E. R., Figg, W. D., et al. (2006) · Blood · doi:10.1182/blood-2006-04-017046 · Cited by 35
In Vivo Formation of a Glutathione Conjugate Derived from Thalidomide in Humanized uPA-NOG Mice
Yamazaki, H., Suemizu, H., Igaya, S., Shimizu, M., Shibata, N., Nakamura, M., Chowdhury, G., & Guengerich, F. P. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200005g · Cited by 34
Cofilin-Mediated Actin Stress Response Is Maladaptive in Heat-Stressed Embryos
Figard, L., Zheng, L., Biel, N., Xue, Z., Seede, H., Coleman, S., Golding, I., & Sokac, A. M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.092 · Cited by 34
Future Trends in Islet Cell Transplantation
Shapiro, A. M. J., & Lakey, J. R. T. (2000) · Diabetes Technology & Therapeutics · doi:10.1089/15209150050194314 · Cited by 34
Rashid, A., Kuppa, A., Kunwar, A., & Panda, D. (2015) · Biochemistry · doi:10.1021/bi501429j · Cited by 33
Murayama, N., van Beuningen, R., Suemizu, H., Guguen‐Guillouzo, C., Shibata, N., Yajima, K., Utoh, M., Shimizu, M., Chesné, C., Nakamura, M., et al. (2014) · Chemical Research in Toxicology · doi:10.1021/tx4004374 · Cited by 33
Schütt, P., Ebeling, P. R., Buttkereit, U., Brandhorst, D., Opalka, B., Poser, M., Müller, S., Flaßhove, M., Moritz, T., Seeber, S., et al. (2005) · Annals of Hematology · doi:10.1007/s00277-005-1007-7 · Cited by 33
Thalidomide Dose Proportionality Assessment following Single Doses to Healthy Subjects
Teo, S. K., Scheffler, M. R., Kook, K. A., Tracewell, W. G., Colburn, W. A., Stirling, D., & Thomas, S. D. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122010555 · Cited by 33
Current status of thalidomide in the treatment of cancer.
Rajkumar, S. V. (2001) · PubMed · Cited by 33
Thalidomide in multiple myeloma
Rajkumar, S. V. (2005) · Community Oncology · doi:10.1016/s1548-5315(11)70861-0 · Cited by 33
Toxicidad pulmonar por talidomida
Valero, F. C., & Bertomeu‐González, V. (2002) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(02)75272-1 · Cited by 33
Dong, D., Yu, J., Wu, Y., Fu, N., Villela, N. L. A., & Yang, P. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.09.137 · Cited by 32
Loh, H. K., Sahoo, K. C., Kishore, K., Ray, R., Nag, T. C., Kumari, S., & Arya, D. S. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00022.x · Cited by 32
Protective effect of oxidative stress in HaCaT keratinocytes expressing E7 oncogene
Shim, J., Kim, K., Cho, Y.-J., Choi, H. S., Song, E. Y., Myung, P. K., Kang, J.-W., Suh, S.-K., Park, S. N., & Yoon, D. (2007) · Amino Acids · doi:10.1007/s00726-007-0499-y · Cited by 32
Hatjiharissi, E., Terpos, E., Papaioannou, M., Hatjileontis, C., Kaloutsi, V. D., Galaktidou, G., Gerotziafas, G., Christakis, J. I., & Zervas, K. (2004) · Hematological Oncology · doi:10.1002/hon.738 · Cited by 32
Thalidomide, an antiangiogenic agent with clinical activity in cancer
Ng, S., Brown, M., & Figg, W. D. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00177-4 · Cited by 32
Tabatabaie, T., Graham, K. L., Vasquez, A. M., Floyd, R. A., & Kotake, Y. (2000) · Nitric Oxide · doi:10.1006/niox.2000.0281 · Cited by 32
Teo, S. K., Scheffler, M. R., Kook, K. A., Tracewell, W. G., Colburn, W. A., Stirling, D., & Thomas, S. D. (2000) · Biopharmaceutics & Drug Disposition · doi:10.1002/1099-081x(200001)21:1<33::aid-bdd213>3.0.co;2-r · Cited by 32
Cibeira, M. T., de Larrea, C. F., Navarro, A., Díaz, T., Fuster, D., Tovar, N., Rosiñol, L., Monzó, M., & Bladé, J. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.02.009 · Cited by 31
Thalidomide for the treatment of multiple myeloma
Hattori, Y., & Iguchi, T. (2004) · Congenital Anomalies · doi:10.1111/j.1741-4520.2004.00025.x · Cited by 31
Wechalekar, A. D., Chen, C. I., Sutton, D., Reece, D. E., Voralia, M., & Stewart, A. K. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000067918 · Cited by 31
Exposition to tannery wastewater did not alter behavioral and biochemical parameters in Wistar rats
Moysés, F. D. S., Bertoldi, K., Spindler, C. D. F., Sanches, E. F., Elsner, V. R., Rodrigues, M. A. S., & Siqueira, I. R. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.02.022 · Cited by 30
Oxidative DNA damage and embryo development
Eriksson, U. J. (1999) · Nature Medicine · doi:10.1038/10420 · Cited by 30
Species differences in methanol and formic acid pharmacokinetics in mice, rabbits and primates
Sweeting, J. N., Siu, M. T., McCallum, G. P., Miller, L., & Wells, P. G. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.05.009 · Cited by 29
Self-citationGene expression of porcine blastocysts from gilts fed organic or inorganic selenium and pyridoxine
Dalto, D. B., Tsoi, S. C. ‐., Audet, I. B., Dyck, M. K., Foxcroft, G. R., & Matte, J. J. (2014) · Reproduction · doi:10.1530/rep-14-0408 · Cited by 29
Differential regulation of dendritic cell function by the immunomodulatory drug thalidomide
Mohty, M., Stoppa, A., Blaise, D., Isnardon, D., Gastaut, J., Olive, D., & Gaugler, B. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.5.939 · Cited by 29
Toxicologic Pathology of the Reproductive System
Woldemeskel, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804239-7.00064-0 · Cited by 28
Liu, C., Qu, G., Cao, M., Liang, Y., Hu, L., Shi, J., Cai, Y. Z., & Jiang, G. (2017) · Aquatic Toxicology · doi:10.1016/j.aquatox.2017.10.014 · Cited by 28
Chernobrovkin, A. L., Cázares-Körner, C., Friman, T., Caballero, I. M., Amadio, D., & Molina, D. M. (2021) · SLAS DISCOVERY · doi:10.1177/2472555220984372 · Cited by 28
Antibody-Induced Transplantation Tolerance: The Role of Dominant Regulation
Graça, L., Moine, A. L., Cobbold, S. P., & Waldmann, H. (2003) · Immunologic Research · doi:10.1385/ir:28:3:181 · Cited by 28
Yamamoto, T., Shibata, N., Sukeguchi, D., Takashima, M., Nakamura, S., Toru, T., Matsunaga, N., Hara, H., Tanaka, M., Obata, T., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.108 · Cited by 28
Evidence for Ras-Dependent Signal Transduction in Phenytoin Teratogenicity
Winn, L., & Wells, P. G. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9504 · Cited by 28
Self-citationThalidomide In Multiple Myeloma: Past, Present and Future
Harousseau, J. (2006) · Future Oncology · doi:10.2217/14796694.2.5.577 · Cited by 28
Miller, L., Shapiro, A. M., Cheng, J., & Wells, P. G. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.02.015 · Cited by 27
Self-citationFox, D. J., Reckless, J., Warren, S. G., & Grainger, D. J. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010984i · Cited by 27
Evaluation of Thalidomide for Treatment or Prevention of Chronic Graft-versus-host Disease
Flowers, M. E. D., & Martin, P. J. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000079096 · Cited by 27
Sandner, S. E., Clarkson, M. R., Salama, A. D., Fueyo, A. S., Yagita∥, H., Turka, L. A., & Sayegh, M. H. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00640.x · Cited by 27
Meyring, M., Mühlenbrock, C., & Blaschke, G. (2000) · Electrophoresis · doi:10.1002/1522-2683(20000901)21:15<3270::aid-elps3270>3.0.co;2-n · Cited by 27
A role for glutathione, independent of oxidative stress, in the developmental toxicity of methanol
Siu, M. T., Shapiro, A. M., Wiley, M. J., & Wells, P. G. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.09.020 · Cited by 26
Self-citationDrake, D. M., Shapiro, A. M., & Wells, P. G. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9182-2_21 · Cited by 26
Self-citationXenograft models for the preclinical evaluation of new therapies in acute leukemia
Lee, E. M., Bachmann, P. S., & Lock, R. B. (2007) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190601113584 · Cited by 26
Apoptosis and transplantation tolerance
Chiffoleau, E., Walsh, P. T., & Turka, L. A. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00037.x · Cited by 26
Lamond, S., Watkinson, M., Rutherford, T. R., Laing, K. G., Whiting, A., Smallwood, A., Nargund, G., Campbell, S. C., & Banerjee, S. (2003) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61884-6 · Cited by 26
Thalidomide in the treatment of multiple myeloma
Rajkumar, S. V. (2001) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.1.1.20 · Cited by 25
Cartilage tissue enhances proteoglycan retention by nucleus pulposus cells in vitro
Arana, C. J., Diamandis, E. P., & Kandel, R. A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27651 · Cited by 25
Anti-inflammatory effect of thalidomide dithiocarbamate and dithioate analogs
Talaat, R. M., Elsayed, W., Agwa, H. S., Gamal‐Eldeen, A. M., Moawia, S., & Zahran, M. A. H. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.05.017 · Cited by 25
Nicolescu, A. C., Comeau, J. L., Hill, B. C., Bedard, L. L., Takahashi, T., Brien, J. F., Racz, W. J., & Massey, T. E. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.031 · Cited by 25
Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma
Arrieta, O. G., Guevara, P., Tamariz, J., Rembao, D., Rivera, E., & Sotelo, J. (2002) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2002.00219.x · Cited by 25
Kennedy, J., Mémet, S., & Wells, P. G. (2004) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)05622-0 · Cited by 25
Self-citationFacilitating the development of molecular glues: Opportunities from serendipity and rational design
Jiang, W., Jiang, Y., Luo, Y., Qiao, W., & Yang, T. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115950 · Cited by 24
Nutt, M. J., & Stewart, S. G. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104010 · Cited by 24
Miller‐Pinsler, L., & Wells, P. G. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1397-1 · Cited by 24
Self-citationMosele, F., Tavares, Â. M. V., Colombo, R., Caron-Lienert, R. S., Araújo, A. S. D. R., Ribeiro, M. F. M., & Belló‐Klein, A. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182550fd6 · Cited by 24
Dalvie, D., Smith, E., Deese, A. J., & Bowlin, S. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008094 · Cited by 24
Yon, J., Baek, I., Lee, S.-R., Jin, Y., Kim, M., Nahm, S., Kim, J.-S., Ahn, B., Lee, B. J., Yun, Y. W., et al. (2007) · Journal of Molecular Histology · doi:10.1007/s10735-007-9134-1 · Cited by 24
Enzymatic resolution and evaluation of enantiomers of cis-5′-hydroxythalidomide
Yamamoto, T., Shibata, N., Takashima, M., Nakamura, S., Toru, T., Matsunaga, N., & Hara, H. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b802459f · Cited by 24
Sekeres, M. A. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.3.369 · Cited by 24
Vargesson, N., Hooper, G., Giddins, G. E. B., Hunter, A., Stirling, P., & Lam, W. (2023) · Journal of Hand Surgery (European Volume) · doi:10.1177/17531934231177425 · Cited by 23
Wang, B., Yu, W., Guo, J., Jiang, X., Lü, W., Liu, M., & Pang, X. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218644 · Cited by 23
Cyclophosphamide and the Teratology society: an awkward marriage
Ozolinš, T. R. S. (2010) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20255 · Cited by 23
Thalidomide inhibits pentylenetetrazole-induced seizures
Palencia, G., Calderón, A., & Sotelo, J. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.03.010 · Cited by 23
Thalidomide in the Treatment of Plasma Cell Malignancies
Rajkumar, S. V., & Kyle, R. A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3593 · Cited by 23
Swartz, M. D., Cai, Y., Chan, W., Symanski, E., Mitchell, L. E., Danysh, H. E., Langlois, P. H., & Lupo, P. J. (2015) · Environmental Health · doi:10.1186/1476-069x-14-16 · Cited by 22
Fluorothalidomide: A Characterization of Maternal and Developmental Toxicity in Rabbits and Mice
Lee, C. J. J., Shibata, N., Wiley, M. J., & Wells, P. G. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr086 · Cited by 22
Self-citationQuantitative AOP based teratogenicity prediction for mixtures of azole fungicides
Battistoni, M., Renzo, F. D., Menegola, E., & Bois, F. Y. (2019) · Computational Toxicology · doi:10.1016/j.comtox.2019.03.004 · Cited by 22
Jeng, W., & Wells, P. G. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn900022w · Cited by 22
Self-citationOxidative Stress and the Metabolic Pathology of Autism
James, S. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-489-0_11 · Cited by 22
Role of Maternal Dietary Antioxidant Supplementation in Murine Placental and Fetal Limb Development
Prater, M. R., Zimmerman, K., Pinn, L. C., Keay, J. M., Laudermilch, C. L., & Holladay, S. D. (2005) · Placenta · doi:10.1016/j.placenta.2005.04.003 · Cited by 22
Recent Progress in Tolerance Induction through Mixed Chimerism
Pree, I., Pilat, N., & Wekerle, T. (2007) · International Archives of Allergy and Immunology · doi:10.1159/000104740 · Cited by 22
Chong, L., Hsu, Y., Chiu, Y., Yang, K., & Huang, Y. (2011) · Phytotherapy Research · doi:10.1002/ptr.3381 · Cited by 22
Thalidomide for the Treatment of Acute Myeloid Leukemia
Steins, M. B., Bieker, R., Padró, T., Keßler, T., Kienast, J., Berdel, W. E., & Mesters, R. M. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190309178769 · Cited by 22
Guan, X., Davis, M. R., Tang, C., Jochheim, C. M., Jin, L., & Baillie, T. A. (1999) · Chemical Research in Toxicology · doi:10.1021/tx990086d · Cited by 22
An ever-changing landscape in Roberts syndrome biology: Implications for macromolecular damage
Mfarej, M. G., & Skibbens, R. V. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1009219 · Cited by 21
Oral dose-ranging developmental toxicity study of an herbal supplement (NT) and gallic acid in rats
Booth, A., Amen, R. J., Scott, M., & Greenway, F. L. (2010) · Advances in Therapy · doi:10.1007/s12325-010-0021-x · Cited by 21
Baek, I., Yon, J., Lee, S. R., Kim, M.-R., Hong, J. T., Lee, B. J., Yun, Y. W., & Nam, S.-Y. (2011) · Anatomia Histologia Embryologia · doi:10.1111/j.1439-0264.2010.01061.x · Cited by 21
Drulă, R., Iluta, S., Gulei, D., Iuga, C. A., Dima, D. M., Ghiaur, G., Buzoianu, A. D., Ciechanover, A. J., & Tomuleasa, C. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.100971 · Cited by 20
Immunomodulatory drugs in multiple myeloma
Zangari, M., Elice, F., & Tricot, G. J. K. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.11.1411 · Cited by 20
Fujita, K., Asami, Y., Tanaka, K., Akita, M., & Merker, H. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0669-x · Cited by 20
Species- and strain-dependent teratogenicity of methanol in rabbits and mice
Sweeting, J. N., Siu, M. T., Wiley, M. J., & Wells, P. G. (2010) · Reproductive Toxicology · doi:10.1016/j.reprotox.2010.09.014 · Cited by 19
Self-citationSingh, D. P., Borse, S., & Nivsarkar, M. (2016) · Translational research · doi:10.1016/j.trsl.2016.03.014 · Cited by 19
Strong anticonvulsant effect of thalidomide on amygdaloid kindling
Palencia, G., Rubio, C., Custodio-Ramirez, V., Paz, C., & Sotelo, J. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.04.008 · Cited by 19
Prolongation of corneal allograft survival by CTLA4-FasL in a murine model
Shi, W., Chen, M., & Xie, L. (2007) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0606-5 · Cited by 18
Factors affecting the early embryonic environment
Johns, J., Jauniaux, E. R. M., & Burton, G. J. (2006) · Reviews in Gynaecological and Perinatal Practice · doi:10.1016/j.rigapp.2006.05.004 · Cited by 18
Persson, B. (2001) · Pediatric Research · doi:10.1203/00006450-200106000-00004 · Cited by 18
Thalidomide for treatment of refractory epilepsy
Palencia, G., Martínez-Juárez, I. E., Calderón, A., Artigas, C., & Sotelo, J. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.10.003 · Cited by 18
Knobloch, J., Schmitz, I., Götz, K., Schulze‐Osthoff, K., & Rüther, U. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00533-07 · Cited by 18
Huang, S., Tang, J., Yao, M., Ko, B.-S., Hong, R., Tsai, W., Wang, C., Tien, H., Shen, M., & Chen, Y. (2003) · Annals of Hematology · doi:10.1007/s00277-003-0700-7 · Cited by 18
Anti‐inflammatory strategies in alcoholic steatohepatitis
Enomoto, N., Takei, Y., Yamashina, S., Ikejima, K., Kitamura, T., & Sato, N. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04652.x · Cited by 17
Adam, A. H. B., Zhang, M., de Haan, L. H. J., van Ravenzwaay, B., Louisse, J., & Rietjens, I. M. C. M. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02487-6 · Cited by 17
Impact of Oxidative Stress on Development
Wells, P. G., Miller‐Pinsler, L., & Shapiro, A. M. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-1405-0_1 · Cited by 17
Self-citationOxidative stress during development: Chemical-induced teratogenesis
Hansen, J. M., Jacob, B. R., & Piorczynski, T. B. (2017) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2017.11.003 · Cited by 17
Death from Metastatic Donor-Derived Ovarian Cancer in a Male Kidney Transplant Recipient
Lipshutz, G. S., Mihara, N., Wong, R., Wallace, W. D., Allen-Auerbach, M., Dorigo, O., Rao, P. N., pham, P.-C. T., & pham, P.-T. T. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02507.x · Cited by 17
Metadata
- Authors
- Parman, T., Wiley, M. J., & Wells, P. G.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Wells, Peter G.
- ORCID
- Wells, Peter G.
- Venue
- Nature Medicine
- Published
- 1999-05
- Volume
- 5
- Issue
- 5
- Pages
- 582-585
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- DOI
- 10.1038/8466
- OpenAlex
- W1568733499
- Semantic Scholar
- 584f5e94f837063f4ceb1b3ddec9c4c9c9ed44ff
- Cited by
- 495
- References
- 25
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 11 · 2023: 2 · 2022: 10 · 2021: 12 · 2020: 10 · 2019: 14 · 2018: 14 · 2017: 10 · 2016: 18 · 2015: 19 · 2014: 13 · 2013: 19 · 2012: 19
- FWCI
- 32.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- thalidomide, teratogenicity, oxidative DNA damage, free radicals, reactive oxygen species, prostaglandin H synthase, horseradish peroxidase, glutathione oxidation, spin trapping, aspirin, embryonic development, congenital malformations
- MeSH terms
- Animals, Cyclic N-Oxides, DNA Damage, Drug Resistance, Embryo, Mammalian, Female, Free Radicals, Hernia, Umbilical, Hypnotics and Sedatives, Nitrogen Oxides, Oxidation-Reduction, Pregnancy, Rabbits, Species Specificity, Teratogens, Thalidomide, Free Radical Scavengers, Limb Deformities, Congenital, Embryo Loss, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.